MEDIUM-CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY
Clinical trials for MEDIUM-CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY explained in plain language.
Never miss a new study
Get alerted when new MEDIUM-CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY trials appear
Sign up with your email to follow new studies for MEDIUM-CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare disorder: testing drug to prevent dangerous blood sugar drops
Disease control Recruiting nowThis study is testing if a medication called triheptanoin is safe and can help prevent low blood sugar (hypoglycemia) in people aged 4 and older with Medium-chain Acyl-CoA Dehydrogenase Deficiency (MCADD), a rare inherited metabolic disorder. Researchers will monitor participants…
Matched conditions: MEDIUM-CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY
Phase: PHASE2 • Sponsor: Jerry Vockley, MD, PhD • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Scientists test how special fats affect rare metabolic disorder
Knowledge-focused Recruiting nowThis study aims to understand how different types of dietary fats affect the body's metabolism in people with Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCADD), a rare inherited metabolic disorder. Researchers will compare 15 MCADD patients with 15 healthy individuals, havin…
Matched conditions: MEDIUM-CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY
Phase: NA • Sponsor: University of Copenhagen • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:25 UTC